Literature DB >> 17301413

A study of malnutrition in Iranian patients with primary antibody deficiency.

Azam Kouhkan1, Zahra Pourpak, Mostafa Moin, Ahmad Reza Dorosty, Reza Safaralizadeh, Shahram Teimorian, Abolhassan Farhoudi, Asghar Aghamohammadi, Mehrnaz Mesdaghi, Anooshiravan Kazemnejad.   

Abstract

Nutrition is an important factor that influences immunity, and nutritional deficiencies can impair resistance to infections. Malnutrition is the most common cause of immunodeficiency worldwide. Trace elements such as zinc, selenium, iron, and copper can influence several components of immunity. Primary antibody deficiency disorders are a group of disorders characterized by an unusual susceptibility to infections and malnutrition. Impaired nutritional status has been reported in immunodeficient patients. The aim of this study was to determine anthropometric indices and trace elements status in these patients. Thirty-eight children (28 males, 10 females, aged 2-18 years) with primary antibody deficiency referring to Children's Medical Center of Tehran University of Medical Science were enrolled in this research. Primary immunodeficiency disorders consisting of CVID, XLA, IgA deficiency, IgG subclass deficiency, and hyper IgM were assessed. Anthropometric indices, comprised of height, weight that were measured and body mass index (BMI) was calculated. Height-for-age (HAZ), weight-for-height (WHZ) and weight-for-age (WAZ) were determined according to Z-score to study mild, moderate and severe malnutrition. Serum copper, zinc, selenium and iron levels were measured by an atomic absorption spectrometer. The most common disorders were CVID 52.5% and X-linked agammaglobulinaemia 27.5%. Based on BMI measurements 21.1% of patients had malnutrition. According to HAZ, 13.2%, 13.2% and 36.8% had severe, moderate and mild malnutrition, respectively. According to WAZ, 10.5%, 18.4% and 28.6% had severe, moderate and mild malnutrition, respectively. Regarding to WHZ, 14.3% and 28.6% had moderate and mild malnutrition, respectively. Low selenium levels and high copper levels were observed in 37.5% and 70.3%, respectively. Anthropometric data showed that the frequency of malnutrition in these patients was higher than the CDC standard. Low serum selenium levels and high serum copper levels were observed, suggesting further research is needed on these parameters. Most of the patients had serum zinc and iron levels within the normal range. It is recommeded that clinical immunologists and nutritionists should make a collective effort to provide these patients with standard or specialized diets so as to decrease the risk of infection.

Entities:  

Year:  2004        PMID: 17301413     DOI: 03.04/ijaai.189196

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  3 in total

1.  Nutritional Status in Agammaglobulinemia: An Italian Multicenter Study.

Authors:  Rosa Maria Dellepiane; Laura Dell'Era; Lorena Vanesa Beilis; Paola Pavesi; Micol Raimondi; Annarosa Soresina; Vassilios Lougaris; Maria Carrabba; Baldassarre Martire; Silvana Martino; Giovanna Russo; Giuseppe Patuzzo; Claudio Pignata; Giuseppe Spadaro; Romina Gallizzi; Marzia Duse; Fernando Giuseppe Specchia; Viviana Moschese; Gian Luigi Marseglia; Maria Cristina Pietrogrande; Giorgio Bedogni; Carlo Agostoni
Journal:  J Clin Immunol       Date:  2015-09-18       Impact factor: 8.317

2.  Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.

Authors:  Eun Sil Kim; Dongsub Kim; Yoonsun Yoon; Yiyoung Kwon; Sangwoo Park; Jihyun Kim; Kang Mo Ahn; Soomin Ahn; Yon Ho Choe; Yae-Jean Kim; Mi Jin Kim
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

3.  The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection.

Authors:  Casandra W Philipson; Josep Bassaganya-Riera; Monica Viladomiu; Mireia Pedragosa; Richard L Guerrant; James K Roche; Raquel Hontecillas
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.